[1]
The Lancet Haematology. Thromboembolism: an under appreciated cause of death. The Lancet. Haematology. 2015 Oct:2(10):e393. doi: 10.1016/S2352-3026(15)00202-1. Epub 2015 Oct 1
[PubMed PMID: 26686033]
[2]
Freund Y, Cohen-Aubart F, Bloom B. Acute Pulmonary Embolism: A Review. JAMA. 2022 Oct 4:328(13):1336-1345. doi: 10.1001/jama.2022.16815. Epub
[PubMed PMID: 36194215]
[3]
Giri J, Sista AK, Weinberg I, Kearon C, Kumbhani DJ, Desai ND, Piazza G, Gladwin MT, Chatterjee S, Kobayashi T, Kabrhel C, Barnes GD. Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association. Circulation. 2019 Nov 12:140(20):e774-e801. doi: 10.1161/CIR.0000000000000707. Epub 2019 Oct 4
[PubMed PMID: 31585051]
[4]
Xue X, Sista AK. Catheter-Directed Thrombolysis for Pulmonary Embolism: The State of Practice. Techniques in vascular and interventional radiology. 2018 Jun:21(2):78-84. doi: 10.1053/j.tvir.2018.03.003. Epub 2018 Mar 8
[PubMed PMID: 29784125]
[5]
Dudzinski DM, Giri J, Rosenfield K. Interventional Treatment of Pulmonary Embolism. Circulation. Cardiovascular interventions. 2017 Feb:10(2):. pii: e004345. doi: 10.1161/CIRCINTERVENTIONS.116.004345. Epub
[PubMed PMID: 28213377]
[6]
McIntyre KM, Sasahara AA. The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. The American journal of cardiology. 1971 Sep:28(3):288-94
[PubMed PMID: 5155756]
[7]
Smulders YM. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovascular research. 2000 Oct:48(1):23-33
[PubMed PMID: 11033105]
[8]
Begieneman MP, van de Goot FR, van der Bilt IA, Vonk Noordegraaf A, Spreeuwenberg MD, Paulus WJ, van Hinsbergh VW, Visser FC, Niessen HW. Pulmonary embolism causes endomyocarditis in the human heart. Heart (British Cardiac Society). 2008 Apr:94(4):450-6
[PubMed PMID: 17646195]
[9]
Burrowes KS, Clark AR, Tawhai MH. Blood flow redistribution and ventilation-perfusion mismatch during embolic pulmonary arterial occlusion. Pulmonary circulation. 2011 Jul-Sep:1(3):365-76. doi: 10.4103/2045-8932.87302. Epub
[PubMed PMID: 22140626]
[10]
Marti C,John G,Konstantinides S,Combescure C,Sanchez O,Lankeit M,Meyer G,Perrier A, Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. European heart journal. 2015 Mar 7;
[PubMed PMID: 24917641]
Level 1 (high-level) evidence
[11]
Dudzinski DM, Piazza G. Multidisciplinary Pulmonary Embolism Response Teams. Circulation. 2016 Jan 5:133(1):98-103. doi: 10.1161/CIRCULATIONAHA.115.015086. Epub
[PubMed PMID: 26719388]
[12]
Yusuff HO, Zochios V, Vuylsteke A. Extracorporeal membrane oxygenation in acute massive pulmonary embolism: a systematic review. Perfusion. 2015 Nov:30(8):611-6. doi: 10.1177/0267659115583377. Epub 2015 Apr 24
[PubMed PMID: 25910837]
Level 1 (high-level) evidence
[13]
Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, Bluhmki E, Bouvaist H, Brenner B, Couturaud F, Dellas C, Empen K, Franca A, Galiè N, Geibel A, Goldhaber SZ, Jimenez D, Kozak M, Kupatt C, Kucher N, Lang IM, Lankeit M, Meneveau N, Pacouret G, Palazzini M, Petris A, Pruszczyk P, Rugolotto M, Salvi A, Schellong S, Sebbane M, Sobkowicz B, Stefanovic BS, Thiele H, Torbicki A, Verschuren F, Konstantinides SV, PEITHO Investigators. Fibrinolysis for patients with intermediate-risk pulmonary embolism. The New England journal of medicine. 2014 Apr 10:370(15):1402-11. doi: 10.1056/NEJMoa1302097. Epub
[PubMed PMID: 24716681]
[14]
Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Áinle FN, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL, The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). The European respiratory journal. 2019 Sep:54(3):. pii: 1901647. doi: 10.1183/13993003.01647-2019. Epub 2019 Oct 9
[PubMed PMID: 31473594]
[15]
Piazza G, Hohlfelder B, Jaff MR, Ouriel K, Engelhardt TC, Sterling KM, Jones NJ, Gurley JC, Bhatheja R, Kennedy RJ, Goswami N, Natarajan K, Rundback J, Sadiq IR, Liu SK, Bhalla N, Raja ML, Weinstock BS, Cynamon J, Elmasri FF, Garcia MJ, Kumar M, Ayerdi J, Soukas P, Kuo W, Liu PY, Goldhaber SZ, SEATTLE II Investigators. A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study. JACC. Cardiovascular interventions. 2015 Aug 24:8(10):1382-1392. doi: 10.1016/j.jcin.2015.04.020. Epub
[PubMed PMID: 26315743]
Level 1 (high-level) evidence
[16]
Jiménez D, Kopecna D, Tapson V, Briese B, Schreiber D, Lobo JL, Monreal M, Aujesky D, Sanchez O, Meyer G, Konstantinides S, Yusen RD, On Behalf Of The Protect Investigators. Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism. American journal of respiratory and critical care medicine. 2014 Mar 15:189(6):718-26. doi: 10.1164/rccm.201311-2040OC. Epub
[PubMed PMID: 24471575]
Level 1 (high-level) evidence
[17]
Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016 Feb:149(2):315-352. doi: 10.1016/j.chest.2015.11.026. Epub 2016 Jan 7
[PubMed PMID: 26867832]
[18]
Sadeghipour P, Jenab Y, Moosavi J, Hosseini K, Mohebbi B, Hosseinsabet A, Chatterjee S, Pouraliakbar H, Shirani S, Shishehbor MH, Alizadehasl A, Farrashi M, Rezvani MA, Rafiee F, Jalali A, Rashedi S, Shafe O, Giri J, Monreal M, Jimenez D, Lang I, Maleki M, Goldhaber SZ, Krumholz HM, Piazza G, Bikdeli B. Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical Trial. JAMA cardiology. 2022 Dec 1:7(12):1189-1197. doi: 10.1001/jamacardio.2022.3591. Epub
[PubMed PMID: 36260302]
Level 1 (high-level) evidence
[19]
Kucher N, Boekstegers P, Müller OJ, Kupatt C, Beyer-Westendorf J, Heitzer T, Tebbe U, Horstkotte J, Müller R, Blessing E, Greif M, Lange P, Hoffmann RT, Werth S, Barmeyer A, Härtel D, Grünwald H, Empen K, Baumgartner I. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation. 2014 Jan 28:129(4):479-86. doi: 10.1161/CIRCULATIONAHA.113.005544. Epub 2013 Nov 13
[PubMed PMID: 24226805]
Level 1 (high-level) evidence
[20]
Tapson VF, Sterling K, Jones N, Elder M, Tripathy U, Brower J, Maholic RL, Ross CB, Natarajan K, Fong P, Greenspon L, Tamaddon H, Piracha AR, Engelhardt T, Katopodis J, Marques V, Sharp ASP, Piazza G, Goldhaber SZ. A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial. JACC. Cardiovascular interventions. 2018 Jul 23:11(14):1401-1410. doi: 10.1016/j.jcin.2018.04.008. Epub
[PubMed PMID: 30025734]
Level 1 (high-level) evidence
[21]
Bashir R, Foster M, Iskander A, Darki A, Jaber W, Rali PM, Lakhter V, Gandhi R, Klein A, Bhatheja R, Ross C, Natarajan K, Nanjundappa A, Angle JF, Ouriel K, Amoroso NE, Firth BG, Comerota AJ, Piazza G, Rosenfield K, Sista AK. Pharmacomechanical Catheter-Directed Thrombolysis With the Bashir Endovascular Catheter for Acute Pulmonary Embolism: The RESCUE Study. JACC. Cardiovascular interventions. 2022 Dec 12:15(23):2427-2436. doi: 10.1016/j.jcin.2022.09.011. Epub 2022 Sep 17
[PubMed PMID: 36121244]
[22]
Engelhardt TC, Taylor AJ, Simprini LA, Kucher N. Catheter-directed ultrasound-accelerated thrombolysis for the treatment of acute pulmonary embolism. Thrombosis research. 2011 Aug:128(2):149-54. doi: 10.1016/j.thromres.2011.05.014. Epub 2011 Jun 8
[PubMed PMID: 21641020]
[23]
Provias T, Dudzinski DM, Jaff MR, Rosenfield K, Channick R, Baker J, Weinberg I, Donaldson C, Narayan R, Rassi AN, Kabrhel C. The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism. Hospital practice (1995). 2014 Feb:42(1):31-7. doi: 10.3810/hp.2014.02.1089. Epub
[PubMed PMID: 24566594]
[24]
Rosovsky R, Zhao K, Sista A, Rivera-Lebron B, Kabrhel C. Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions. Research and practice in thrombosis and haemostasis. 2019 Jul:3(3):315-330. doi: 10.1002/rth2.12216. Epub 2019 Jun 9
[PubMed PMID: 31294318]
[25]
Mahar JH, Haddadin I, Sadana D, Gadre A, Evans N, Hornacek D, Mahlay NF, Gomes M, Joseph D, Serhal M, Tong MZ, Bauer SR, Militello M, Silver B, Shishehbor M, Bartholomew JR, Heresi GA. A pulmonary embolism response team (PERT) approach: initial experience from the Cleveland Clinic. Journal of thrombosis and thrombolysis. 2018 Aug:46(2):186-192. doi: 10.1007/s11239-018-1686-2. Epub
[PubMed PMID: 29855780]
[26]
Braaten JV, Goss RA, Francis CW. Ultrasound reversibly disaggregates fibrin fibers. Thrombosis and haemostasis. 1997 Sep:78(3):1063-8
[PubMed PMID: 9308755]
[27]
Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet (London, England). 1999 Apr 24:353(9162):1386-9
[PubMed PMID: 10227218]
Level 2 (mid-level) evidence
[28]
Avgerinos ED, Saadeddin Z, Abou Ali AN, Fish L, Toma C, Chaer M, Rivera-Lebron BN, Chaer RA. A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism. Journal of vascular surgery. Venous and lymphatic disorders. 2018 Jul:6(4):530-540. doi: 10.1016/j.jvsv.2018.03.010. Epub
[PubMed PMID: 29909859]
Level 1 (high-level) evidence
[29]
Mostafa A, Briasoulis A, Telila T, Belgrave K, Grines C. Treatment of Massive or Submassive Acute Pulmonary Embolism With Catheter-Directed Thrombolysis. The American journal of cardiology. 2016 Mar 15:117(6):1014-20. doi: 10.1016/j.amjcard.2015.12.041. Epub 2015 Dec 31
[PubMed PMID: 26833207]
[30]
de Winter MA, Vlachojannis GJ, Ruigrok D, Nijkeuter M, Kraaijeveld AO. Rationale for catheter-based therapies in acute pulmonary embolism. European heart journal supplements : journal of the European Society of Cardiology. 2019 Nov:21(Suppl I):I16-I22. doi: 10.1093/eurheartj/suz223. Epub 2019 Nov 21
[PubMed PMID: 31777453]
[31]
Giri JS, Piazza G. A midterm report card for pulmonary embolism response teams. Vascular medicine (London, England). 2018 Feb:23(1):72-74. doi: 10.1177/1358863X17738337. Epub 2017 Oct 16
[PubMed PMID: 29034789]
[32]
Porres-Aguilar M, Anaya-Ayala JE, Heresi GA, Rivera-Lebron BN. Pulmonary Embolism Response Teams: A Novel Approach for the Care of Complex Patients With Pulmonary Embolism. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 2018 Dec:24(9_suppl):48S-55S. doi: 10.1177/1076029618812954. Epub 2018 Nov 19
[PubMed PMID: 30453745]